What DocGo Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 1 |
| Total trades | 0 | 14 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 2,563,955 |
| Disposed | 0 | 367,178 |
| Net activity | +0 | +2,196,777 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bienstock Lee | Chief Executive Officer | May 12 | Withheld — tax / exercise cost · F | −15,644 | $0.59 | −$9.23K | 2,801,826 |
| Bienstock Lee | Chief Executive Officer | Mar 30 | Withheld — tax / exercise cost · F | −18,811 | $0.57 | −$10.7K | 2,817,470 |
| Bienstock Lee | Chief Executive Officer | Dec 15 | Withheld — tax / exercise cost · F | −214,131 | $0.91 | −$195K | 2,836,281 |
| Sugrue Stephen | Chief Compliance Officer | Dec 15 | Withheld — tax / exercise cost · F | −35,968 | $0.91 | −$32.7K | 636,602 |
| Tendler Ely D | General Counsel and Secretary | Dec 15 | Sale for tax withholding · S | −16,850 | $0.91 | −$15.3K | 258,795 |
| Rosenberg Norman | CFO and Treasurer | Dec 15 | Withheld — tax / exercise cost · F | −65,774 | $0.91 | −$59.9K | 1,223,571 |
| Burdiek Michael J | Director | Dec 12 | Grant / award · A | +150,000 | — | — | 791,560 |
| Bienstock Lee | Chief Executive Officer | Dec 12 | Grant / award · A | +1,113,495 | — | — | 3,050,412 |
| Smedra Ira | Director | Dec 12 | Grant / award · A | +150,000 | — | — | 240,999 |
| Leite Etalvina | Director | Dec 12 | Grant / award · A | +150,000 | — | — | 201,411 |
| Sugrue Stephen | Chief Compliance Officer | Dec 12 | Grant / award · A | +321,055 | — | — | 672,570 |
| Tendler Ely D | General Counsel and Secretary | Dec 12 | Grant / award · A | +100,000 | — | — | 275,645 |
| Travers James M | Director | Dec 12 | Grant / award · A | +150,000 | — | — | 240,999 |
| Rosenberg Norman | CFO and Treasurer | Dec 12 | Grant / award · A | +429,405 | — | — | 1,289,345 |
| Klasko Stephen K. M.d. | Director | Sep 10 | Grant / award · A | +100,000 | — | — | 115,000 |
| Bienstock Lee | Chief Executive Officer | Jul 02 | Withheld — tax / exercise cost · F | −18,597 | $1.52 | −$28.3K | 1,936,917 |
| Sugrue Stephen | Chief Compliance Officer | Jul 02 | Withheld — tax / exercise cost · F | −5,813 | $1.52 | −$8.84K | 351,515 |
| Rosenberg Norman | CFO and Treasurer | Jul 02 | Withheld — tax / exercise cost · F | −11,332 | $1.52 | −$17.2K | 859,940 |
| Burdiek Michael J | Director | May 23 | Open-market buy · P | +10,000 | $1.33 | +$13.3K | 641,560 |
| Burdiek Michael J | Director | May 15 | Open-market buy · P | +15,000 | $1.43 | +$21.5K | 631,560 |
Loading...
